Real-time enrollment status for this her2-positive breast cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:56 AM UTC
| NCT Number | NCT04332588 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT04332588 is currently recruiting participants. This phase1 study for her2-positive breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04332588 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04332588 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.